Home › Brain Diseases › Florida › Miami
Brain Diseases clinical trials in Miami, FL
6 studies for Brain Diseases are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- BRP-Kendal Lakes, Miami
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RecruitingPhase 2
- Vima Site #008, Miami
CoMind Early Feasibility Study
RecruitingObservational study
- Jackson Memorial Hospital, Miami
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, Miami
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
- Clinical Site, Miami
- Clinical Site, Miami
- Clinical Site, Miami
- and 1 more
Open-label Extension Study in Participants With Early Alzheimer's Disease
RecruitingPhase 2
- GSK Investigational Site, Miami
About Brain Diseases
Brain diseases affect different functions of the body from memory, speech, thinking clearly, how well the different organs work, or even movement.
More about Brain Diseases on MedlinePlus
Brain Diseases trials in other cities
- New York City, NY7 studies
- Orlando, FL7 studies
- Boston, MA7 studies
- St. Louis, MO7 studies
- Houston, TX6 studies
- Pittsburgh, PA6 studies
- Washington, DC6 studies
- Philadelphia, PA5 studies
- San Diego, CA5 studies
- Atlanta, GA4 studies
- West Palm Beach, FL4 studies
- Akron, OH4 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer28 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Ulcerative Colitis22 studies
- Alzheimer's Disease21 studies
- Multiple Myeloma21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.